IBM CEO: Watson Health is ‘Our Moonshot’ in Healthcare
By Greg Slabodkin,
Health Data Management
| 04. 20. 2015
Untitled Document
A new IBM business unit launched last week to help physicians, researchers, insurers and patients use big data, analytics and mobile technology to achieve better health outcomes is being described by the company’s chief executive officer as their “moonshot” in healthcare.
“If you go back in time, we have participated in some of the most glorious moments of history, whether it might have been the first systems that ever did census and landing a man on the moon,” said Ginni Rometty, chairman and CEO of IBM, on PBS’s Charlie Rose talk show. “I’m telling you our moonshot will be the impact we will have on healthcare. It has already started. We will do our part to change the face of healthcare. I am absolutely positive about it.”
Last week, IBM announced a new business unit—Watson Health—that will offer cloud-based access to its Watson supercomputer for analyzing healthcare data. Big Blue has partnered with Apple, Johnson & Johnson and Medtronic to make it easier for healthcare organizations to store and analyze patient data by leveraging Watson’s cognitive capabilities and...
Related Articles
By Elizabeth Dwoskin and Zoeann Murphy, The Washington Post | 10.01.2025
MEXICO CITY — When she walked into an IVF clinic in June, Alin Quintana knew it would be the last time she would try to conceive a child. She had prepared herself spiritually and mentally for the visit: She had traveled to a nearby...
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Jessica Mouzo, El País | 10.03.2025
DNA is the molecule of life: this double-helix structure, present in every cell in the body and organized into fragments called genes, stores the instructions for making organisms function. It is a highly precise biological machine, but sometimes it breaks...
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
